Arrowstreet Capital’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Arrowstreet Capital's VCYT Position: Q2 2026 in Review
Arrowstreet Capital increased its Veracyte (VCYT) stake by 275% in Q2 2026, buying an estimated $16.3M and bringing the position to 531,572 shares worth $31.2M. The position accounts for 0.01% of the portfolio, ranked #715.
Arrowstreet Capital first reported a position in VCYT in Q4 2019 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Arrowstreet Capital held 531,572 shares of Veracyte worth $31.2M as of Q2 2026.
- Arrowstreet Capital bought 389,761 Veracyte shares in Q2 2026, an estimated $16.3M.
- Veracyte made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #715 holding.
- Arrowstreet Capital first reported a position in Veracyte in Q4 2019 and has held it in 7 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.